Castleview Partners’s Cabot Corp CBT Stock Holding History

Castleview Partners’s Portfolio CBT Stock Details CBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10	Closed	-$919	–	595
2024 Q2	$919	Hold	10	–	–	﹤0.01%	817
2024 Q1	$922	Buy	+10	New	+$813	﹤0.01%	804

Other funds holding CBT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Castleview Partners's CBT Position: Q3 2024 in Review

Castleview Partners sold out of Cabot Corp (CBT) in Q3 2024, closing a stake of 10 shares — an estimated $919 sold.

Castleview Partners first reported a position in CBT in Q1 2024 and held it in 2 quarters. The position peaked at $922 in Q1 2024. 407 funds tracked by Wall St. Rank hold CBT as of Q3 2024.

Castleview Partners reported no remaining Cabot Corp position as of Q3 2024 after selling out during the quarter.
Castleview Partners sold 10 Cabot Corp shares in Q3 2024, an estimated $919.
Castleview Partners first reported a position in Cabot Corp in Q1 2024 and held it in 2 quarters.
Castleview Partners's Cabot Corp position peaked at $922 in Q1 2024.
407 funds tracked by Wall St. Rank held Cabot Corp as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.